Carvitop 3.125mg Tablet IR

generic_icon
Rs.29.10for 1 strip(s) (10 tablet ir each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Carvitop 3.125mg Tablet IR

Carvedilol(3.125mg)

food interaction for Carvitop Tablet IR

alcohol interaction for Carvitop Tablet IR

pregnancy interaction for Carvitop Tablet IR

lactation interaction for Carvitop Tablet IR

food
alcohol
pregnancy
lactation
Carvitop 3.125mg Tablet IR is to be taken with food.
None
CAUTION
It is unsafe to consume alcohol with Carvitop 3.125mg Tablet IR.
UNSAFE
Carvitop 3.125mg Tablet IR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Carvitop 3.125mg Tablet IR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED

SALT INFORMATION FOR Carvitop 3.125mg Tablet IR

Carvedilol(3.125mg)

Carvitop tablet ir uses

How carvitop tablet ir works

Carvitop 3.125mg Tablet IR is an alpha and beta blocker. It works by slowing down the heart rate and relaxing blood vessels which makes the heart more efficient at pumping blood around the body.

Common side effects of carvitop tablet ir

Decreased blood pressure, Headache, Fatigue, Dizziness, Breathlessness

SUBSTITUTES FOR Carvitop Tablet IR

No substitutes found

Expert advice FOR Carvitop Tablet IR

  • It should be taken with food.
  • Check your blood pressure 1 week after starting Carvedilol, and inform your doctor if it has not improved.
  • Carvedilol may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
  • It is best to avoid drinking alcohol while taking Carvedilol as it may make the side effects worse.
  • Do not stop taking Carvedilol suddenly as it can cause your blood pressure to rise suddenly, thereby increasing the risk of heart attack and stroke.

Frequently asked questions FOR Carvitop 3.125mg Tablet IR

Carvedilol

Q. What happens when you stop taking Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR needs to be taken regularly as directed by your doctor. Suddenly stopping it may cause chest pain or heart attack. Your doctor may slowly lower your dose over a period of time before stopping it completely if required.
Q. Does Carvitop 3.125mg Tablet IR make you tired?
Yes, Carvitop 3.125mg Tablet IR may make you tired as well as dizzy. These may occur initially when you start the treatment or when the dose is increased. If you experience these symptoms you should not drive or operate machinery.
Q. Can Carvitop 3.125mg Tablet IR cause weight gain?
Yes, weight gain is a common side effect of Carvitop 3.125mg Tablet IR, but it does not occur in everyone. If you are taking Carvitop 3.125mg Tablet IR for heart failure, tell your doctor if you gain weight or have trouble breathing, as this may be a sign of fluid retention.
Show More
Q. Can Carvitop 3.125mg Tablet IR cause kidney failure?
Use of Carvitop 3.125mg Tablet IR in patients with heart failure can rarely lead to deterioration of kidney function. However, Carvitop 3.125mg Tablet IR may cause risk of kidney failure in patients with low blood pressure (systolic blood pressure less than 100 mm Hg), patients with hardening of the arteries and/or having heart disease, or already have impaired kidney function. Such patients should be closely monitored during treatment with Carvitop 3.125mg Tablet IR. Although, kidney functions return to baseline when Carvitop 3.125mg Tablet IR is stopped.
Q. Can a diabetic patient take Carvitop 3.125mg Tablet IR?
Yes, a diabetic patient can take Carvitop 3.125mg Tablet IR, provided that there is a regular check on blood glucose levels. It has been noted that in well-controlled diabetes mellitus with mild to moderate hypertension, Carvitop 3.125mg Tablet IR did not have any effect on blood glucose levels. However, it is important to know that, using Carvitop 3.125mg Tablet IR class of medicines (beta-blockers) may hide the symptoms of hypoglycemia (decrease in glucose levels), especially an increase in heartbeat or palpitations. In addition to that, Carvitop 3.125mg Tablet IR may cause worsening of hyperglycemia (increase in blood glucose levels) in patients with heart failure and diabetes. Hence, it is recommended that blood glucose should be monitored while initiating, adjusting, or discontinuing the dose of Carvitop 3.125mg Tablet IR. Inform the doctor if there is any change in blood glucose levels during Carvitop 3.125mg Tablet IR therapy.
Q. Can I take Carvitop 3.125mg Tablet IR empty stomach?
It is recommended that you take Carvitop 3.125mg Tablet IR with food, as food decreases the rate at which the medicine gets absorbed by the body. This will help to reduce the chances of orthostatic hypotension (low blood pressure which may cause dizziness or fainting when you stand up).
Q. What are the serious side effects of Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR may cause serious side effects such as fainting, shortness of breath, weight gain, swelling of the arms, hands, feet, ankles, or lower legs. Some may also experience chest pain, slow or irregular heartbeat, rash, hives, itching, and difficulty in breathing and swallowing. If you experience any of these symptoms call your doctor immediately.
Q. What if I take more than the recommended dose of Carvitop 3.125mg Tablet IR?
If you take more than the recommended dose of Carvitop 3.125mg Tablet IR you may experience slow heartbeat, dizziness, fainting, difficulty breathing, vomiting, and loss of consciousness or seizures. Contact your doctor and seek immediate medical help in a nearby hospital.
Q. Who should not take Carvitop 3.125mg Tablet IR?
Carvitop 3.125mg Tablet IR should be avoided if the patient has severe heart failure and is hospitalized in the intensive care unit or require certain intravenous medications that help support circulation (inotropic medications). In addition to that, Carvitop 3.125mg Tablet IR should be avoided in patients who are prone to asthma or other breathing problems, have a slow heartbeat or irregular heartbeat, have liver problems, and are allergic to Carvitop 3.125mg Tablet IR.

Content on this page was last updated on 30 September, 2024, by Dr. Varun Gupta (MD Pharmacology)